A Study of AMG 732 in Healthy Participants and Participants With Thyroid Eye Disease
Clinical trial NCT06401044 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06401044
- Sponsor
- Amgen
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-30
- Primary completion
- 2027-01-06
- Enrollment
- 94
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.